Literature DB >> 8706880

A mutation which disrupts the hydrophobic core of the signal peptide of bilirubin UDP-glucuronosyltransferase, an endoplasmic reticulum membrane protein, causes Crigler-Najjar type II.

J Seppen1, E Steenken, D Lindhout, P J Bosma, R P Elferink.   

Abstract

Crigler-Najjar (CN) disease is caused by a deficiency of the hepatic enzyme, bilirubin UDP-glucuronosyltransferase (B-UGT). We have found two CN type II patients, who were homozygous for a leucine to arginine transition at position 15 of B-UGT1. This mutation is expected to disrupt the hydrophobic core of the signal peptide of B-UGT1. Wild type and mutant B-UGT cDNAs were transfected in COS cells. Mutant and wild type mRNA were formed in equal amounts. The mutant protein was expressed with 0.5% efficiency, as compared to wild type. Mutant and wild type mRNAs were translated in vitro. Wild type transferase is processed by microsomes, no processing of the mutant protein was observed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8706880     DOI: 10.1016/0014-5793(96)00677-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  An impaired routing of wild-type aquaporin-2 after tetramerization with an aquaporin-2 mutant explains dominant nephrogenic diabetes insipidus.

Authors:  E J Kamsteeg; T A Wormhoudt; J P Rijss; C H van Os; P M Deen
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

2.  Signal peptide variants that impair secretion of pancreatic secretory trypsin inhibitor (SPINK1) cause autosomal dominant hereditary pancreatitis.

Authors:  Orsolya Király; Arnaud Boulling; Heiko Witt; Cédric Le Maréchal; Jian-Min Chen; Jonas Rosendahl; Cinzia Battaggia; Thomas Wartmann; Miklós Sahin-Tóth; Claude Férec
Journal:  Hum Mutat       Date:  2007-05       Impact factor: 4.878

3.  Silencing of Aberrant Secretory Protein Expression by Disease-Associated Mutations.

Authors:  Elena B Tikhonova; Zemfira N Karamysheva; Gunnar von Heijne; Andrey L Karamyshev
Journal:  J Mol Biol       Date:  2019-05-14       Impact factor: 5.469

Review 4.  Germline genetic variants with implications for disease risk and therapeutic outcomes.

Authors:  Amy L Pasternak; Kristen M Ward; Jasmine A Luzum; Vicki L Ellingrod; Daniel L Hertz
Journal:  Physiol Genomics       Date:  2017-09-08       Impact factor: 3.107

Review 5.  INS-gene mutations: from genetics and beta cell biology to clinical disease.

Authors:  Ming Liu; Jinhong Sun; Jinqiu Cui; Wei Chen; Huan Guo; Fabrizio Barbetti; Peter Arvan
Journal:  Mol Aspects Med       Date:  2014-12-24

6.  Prediction of deleterious non-synonymous single-nucleotide polymorphisms of human uridine diphosphate glucuronosyltransferase genes.

Authors:  Yuan Ming Di; Eli Chan; Ming Qian Wei; Jun-Ping Liu; Shu-Feng Zhou
Journal:  AAPS J       Date:  2009-07-02       Impact factor: 4.009

7.  Six novel UDP-glucuronosyltransferase (UGT1A3) polymorphisms with varying activity.

Authors:  Masaru Iwai; Yoshihiro Maruo; Masaki Ito; Kazuo Yamamoto; Hiroshi Sato; Yoshihiro Takeuchi
Journal:  J Hum Genet       Date:  2004-02-18       Impact factor: 3.172

8.  Identification and molecular characterisation of a homozygous missense mutation in the ADAMTS10 gene in a patient with Weill-Marchesani syndrome.

Authors:  Hannes Steinkellner; Julia Etzler; Laura Gogoll; Jürgen Neesen; Eva Stifter; Oliver Brandau; Franco Laccone
Journal:  Eur J Hum Genet       Date:  2014-12-03       Impact factor: 4.246

Review 9.  Quality Control of Orphaned Proteins.

Authors:  Szymon Juszkiewicz; Ramanujan S Hegde
Journal:  Mol Cell       Date:  2018-08-02       Impact factor: 17.970

10.  Permanent neonatal diabetes due to a novel insulin signal peptide mutation.

Authors:  Suhaimi Hussain; Johari Mohd Ali; Muhammad Yazid Jalaludin; Fatimah Harun
Journal:  Pediatr Diabetes       Date:  2013-01-28       Impact factor: 4.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.